# Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling

> **NCT02613962** · NA · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 791 (actual)

## Conditions studied

- Relapsed or Refractory Pediatric Tumor

## Interventions

- **PROCEDURE:** biopsy or surgical resection of tumor and blood sampling

## Key facts

- **NCT ID:** NCT02613962
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-13
- **Primary completion:** 2022-11-16
- **Final completion:** 2022-11-16
- **Target enrollment:** 791 (ACTUAL)
- **Last updated:** 2026-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02613962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02613962, "Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02613962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*